Skip to Main Content

Benjamin N. Breyer


Urologic surgeon
Dedicated to urinary and sexual health in men

Dr. Benjamin Breyer is a urologic surgeon who specializes in complex urethral and penile reconstruction, male incontinence, male fistulas and surgery for erectile dysfunction.

Breyer's research has been federally supported and focuses on the epidemiology (the study of which populations are affected by diseases, factors affecting outcomes and related matters) of sexual dysfunction and lower urinary tract disorders. He also studies urologic trauma and surgical repair of the urinary tract. He has authored or co-authored more than 350 articles and book chapters.

Breyer earned his medical degree from the Pritzker School of Medicine at the University of Chicago. At UCSF, he completed a residency in urology, followed by a fellowship in male genitourinary reconstruction and trauma. He also earned his master of advanced study degree in clinical research at UCSF.

  • Education

    University of Chicago Pritzker School of Medicine, 2003

  • Residencies

    UCSF, Urology, 2009

  • Fellowships

    UCSF, Male Genitourinary Trauma and Reconstruction, 2011

  • Board Certifications

    Urology, American Board of Urology

  • Academic Title


I treat my patients like family, seeking to be an ally and advocate. I help them improve their urinary and sexual wellness after cancer or trauma.

Where I see patients (1)

    My reviews


    Overall Experience
    483 Ratings
    Explained things in a way that was easy to understand
    481 Ratings
    Did the doctor pay attention to your concerns
    481 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    470 Ratings
    Knew the important information about your medical history
    479 Ratings
    The provider showed respect for what you had to say
    481 Ratings
    The provider spent enough time with me
    480 Ratings
    Decorative Caduceus

    Artificial Urinary Sphincter Clinical Outcomes

    Number of subjects achieving 50% reduction or greater in baseline urinary incontinence as measured by 24-hour pad weight test at 12 months post device activation


    Decorative Caduceus

    The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe H...

    Pre-post changes in mean episodes of visible blood in urine (or blood clots) on 3-day bladder diaries at baseline and primary endpoint